novavax inc (NVAX:NASDAQ GS)

Executive Profile*

Background*

Dr. Timothy Jon Hahn, Ph.D, Tim has been Senior Vice President of Manufacturing and Process Development at Novavax, Inc. since October 2011. Dr. Hahn oversees production of the Novavax's vaccines and vaccine candidates and be responsible for all manufacturing operations at its pilot and commercial launch facility in Rockville, MD. He served as a Senior Vice President of Manufacturing at Novavax, Inc. since June 2011. Prior to joining Novavax, Dr. Hahn served as Vice ... President of Antibody Manufacturing at MedImmune Limited and Vice President of Vaccine Manufacturing at MedImmune, LLC. In these roles and as a member of the operations manufacturing team, he oversaw MedImmune's U.S. manufacturing sites in Frederick, MD and Philadelphia, PA and non-U.S. sites in Nijmegen, The Netherlands and Speke, UK with responsibility for bulk and fill production of commercial antibody and vaccine products as well as fill manufacturing of clinical trial materials. Dr. Hahn also coordinated the management of the integrated production processes for the seasonal production of Synagis(R) and FluMist(R). As part of the leadership team for the start-up of a new antibody manufacturing facility in Frederick, MD, Dr. Hahn was responsible for the process validation and start-up strategy and execution for the project, which was recognized as the 2011 ISPE Facility of the Year Award Winner for Project Execution. Previously, Dr. Hahn spent more than 15 years in vaccine manufacturing with Merck & Co. He received his doctorate and Master of Science degrees in chemical engineering from Stanford University and his Bachelor of Science degree in chemical engineering from Lehigh University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
NVAX:US	$2.02 USD	-0.02

COMPETITOR COMPENSATION